Potential Adverse Events Following Immunization

Updated November 7, 2023

Contents

Summaries of the Evidence

This section addresses the numerous potential adverse events that have been studied in order to determine if an association exists with routine immunization in the United States, and supplements the vaccine information summaries for those seeking more information about a specific adverse event.

The independent 2012 report by the Institute of Medicine (IOM), now called the National Academy of Medicine (NAM), entitled Adverse Effects of Vaccines: Evidence and Causality 1 was relied upon heavily to compile both the list of adverse events and the sources providing the best evidence for each adverse event. The 2014 and 2021 reports by the Agency for Healthcare Research and Quality (AHRQ) entitled Safety of Vaccines Used for Routine Immunization in the United States (Evidence Report/Technology Assessment No. 215) 2 and Safety of Vaccines Used for Routine Immunization in the United States: An Update (Comparative Effectiveness Review No. 244) 3 were used to update and supplement the IOM report, as well as our own systematic literature searches and general knowledge. The aforementioned AHRQ reports were also summarized in review articles in the journals Pediatrics 4 and Vaccine 5, respectively.

In order to consistently and succinctly characterize the frequency of adverse events in this section, definitions used by the World Health Organization are used here, as outlined in the table below.

Standard Categories of Frequency for Adverse Drug Reactions provided by “Guidelines for Preparing Core Clinical-Safety Information on Drugs” – Report of CIOMS Working Group III (1995)

CategoriesDefinitions
Very common≥ 1/10 (≥ 10%)
Common≥ 1/100 and < 1/10 (~1%-10%)
Uncommon≥ 1/1,000 and < 1/100 (~0.1-1%)
Rare≥ 1/10,000 and < 1/1,000 (~0.01-0.1%)
Very rare< 1/10,000 (< 0.01%)

In order to summarize the evidence regarding potential adverse events in an accurate, concise, practical and standardized manner, we established the categories of causality conclusions outlined the table below.

Categories of Causality Conclusions*

CategoriesDefinitions
Vaccines can cause the event.The evidence shows a clear association between the event and at least one vaccine routinely recommended in the U.S.
Vaccines did cause the event.The evidence showed a clear association between the event and at least one previously recommended vaccine. However, these vaccine(s) are no longer used in the U.S., if they ever were.
Vaccines have not been shown to cause the event.The evidence of an association between the event and vaccines currently routinely recommended to the general population in the United States is insufficient or non-existent.
Vaccines do not cause the event.The evidence shows clear lack of association between the event and vaccines currently routinely recommended to the general population in the United States.
* These conclusions do not necessarily consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel), or vaccines no longer recommended to the public such as the Janssen (J&J) COVID-19 vaccine.

Regarding the category, ‘Vaccines have not been shown to cause the event,’ some may misrepresent conclusions such as this to suggest that the adverse event in question has not been examined and therefore is likely, offering personal anecdotes in support of their argument. We caution against such interpretations. In most of these instances, the specific condition in question is quite rare in the general population (for example, affecting fewer than 1 in 10,000 individuals in a given year). Simply because of their rarity, it is very difficult to quantify risk estimates for such conditions. In almost all cases where we conclude “Vaccines have not been shown to cause the event,” if there were a risk greater than our category of ‘very rare,’ (<1:10,000), that risk would have been detected under existing surveillance systems. For rare conditions, it is inherently difficult to quantify very rare risks.

We summarize several special topics of interest related to vaccine safety, as shown in the table below.

Special Topics of Interest Related To Vaccines Currently Routinely Recommended for The General Population in The United States*

TopicConclusion
Combination Vaccines or Simultaneous VaccinationMMRV can rarely cause febrile seizures in infants and young children, at slightly higher rates than individual administration of MMR and varicella vaccines. Simultaneous administration of influenza and pneumococcal conjugate vaccines can rarely cause febrile seizures in infants and young children, at slightly higher rates than separate administration of these vaccines. No other adverse events have been shown to be caused by combination vaccines or simultaneous vaccination as compared to separate administration of available individual vaccine components.
Vaccine IngredientsCertain ingredients found in some vaccines, such as gelatin or neomycin, can very rarely cause severe hypersensitivity reactions (e.g. anaphylaxis) in those who are allergic to these specific ingredients.

The summaries of potential adverse events are arranged in alphabetical order. They have also been organized by the conclusions drawn in the tables below for convenience purposes. For the majority of these potential adverse events, there are no studies of quality that show an association with routine immunization in the United States.

Causal Relationship Established With Vaccines Currently Routinely Recommended for The General Population in The United States*

Adverse Event Conclusion
AnaphylaxisVaccine components can very rarely cause anaphylaxis.
Arthralgia/Arthritis (mild, acute, transient – not chronic)Rubella-containing vaccines can cause mild, acute, transient arthralgia or arthritis, very commonly in adult women but rarely in children. Other U.S. vaccines have not been shown to cause arthralgia or arthritis.   Vaccines have not been shown to cause chronic arthralgia/arthritis, as stated in the table below.
Deltoid Bursitis/Shoulder Injury Related to Vaccination (SIRVA)Incorrect administration of vaccines can cause deltoid bursitis/SIRVA.
Disseminated Varicella InfectionVaricella vaccine can rarely cause disseminated varicella infection in immune deficient individuals for whom the vaccine is contraindicated.
EncephalitisMeasles vaccine can very rarely cause encephalitis. Mumps vaccine used in other countries did cause encephalitis (but not the vaccine licensed in the U.S.).
Febrile SeizuresVaccines that induce fever in infants and young children, such as MMRV, influenza, and PCV vaccines, can rarely cause febrile seizures.
Guillain-Barré Syndrome (GBS)Influenza vaccine can cause GBS very rarely in adults. An old formulation of rabies vaccine (no longer available) did cause GBS. Other vaccines, including current rabies vaccine, have not been shown to cause GBS.
HepatitisVaricella vaccine can rarely cause hepatitis if administered to persons with certain immune deficiencies. Vaccines given to immunocompetent persons do not cause hepatitis.
Herpes ZosterVaricella vaccine can rarely cause herpes zoster due to vaccine-strain viral reactivation.
Immune Thrombocytopenic Purpura (ITP)MMR vaccine can very rarely cause ITP in children.
MeningitisReactivation of varicella vaccine can very rarely cause meningitis. Mumps vaccine used in other countries (but not the vaccine licensed in the U.S.) did cause meningitis.
SyncopeVaccines (and other injections) can rarely cause syncope.
* These conclusions do not necessarily consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel).

No Causal Relationship Established With Vaccines Currently Routinely Recommended for the General Population in The United States*

Adverse EventConclusion
Acute Disseminated Encephalomyelitis (ADEM)An old formulation of rabies vaccine (no longer available) did cause ADEM.  Other vaccines, including current rabies vaccine, have not been shown to cause ADEM.
Arthralgia/Arthritis (chronic)Vaccines have not been shown to cause chronic arthralgia/arthritis.
AsthmaInfluenza vaccines do not cause asthma. Other vaccines have not been shown to cause asthma.
AtaxiaVaccines have not been shown to cause ataxia.
AutismChildhood vaccines do not cause autism. Maternal vaccines have not been shown to cause autism.
Brachial NeuritisVaccines have not been shown to cause brachial neuritis.
Chronic Fatigue SyndromeVaccines have not been shown to cause chronic fatigue syndrome.
Chronic Inflammatory Disseminated Polyneuropathy (CIDP)Vaccines have not been shown to cause CIDP.
Chronic UrticariaVaccines have not been shown to cause chronic urticaria.
Complex Regional Pain Syndrome (CRPS)Vaccines have not been shown to cause CRPS.
DiabetesVaccines do not cause diabetes.
EpilepsyVaccines have not been shown to cause epilepsy.
Erythema NodosumVaccines have not been shown to cause erythema nodosum.
FibromyalgiaVaccines have not been shown to cause fibromyalgia.
Hearing LossVaccines have not been shown to cause hearing loss.
Infantile SpasmsVaccines have not been shown to cause infantile spasms.
Multiple Sclerosis (MS)Influenza vaccine does not cause MS in adults. Influenza vaccine has not been shown to cause MS in children. Other vaccines have not been shown to cause MS.
Myocardial Infarction (MI)Vaccines have not been shown to cause MI.
Myocarditis Smallpox vaccine can very rarely cause myocarditis, but is not routinely recommended to the general population in the U.S. Other vaccines have not been shown to cause myocarditis.
NarcolepsyCurrent vaccines have not been shown to cause narcolepsy. AS03-adjuvanted 2009 pandemic H1N1 influenza vaccine used in Europe (not used in the U.S.) did very rarely cause narcolepsy.
Neuromyelitis OpticaVaccines have not been shown to cause neuromyelitis optica.
Oculorespiratory syndrome (ORS)Two influenza vaccines used in Canada (but not used in the U.S.) did commonly cause ORS. Changes made to the formulation of these vaccines have resulted in a dramatic decrease in the risk of ORS.
Opsoclonus Myoclonus SyndromeVaccines have not been shown to cause opsoclonus myoclonus syndrome.
Optic NeuritisVaccines have not been shown to cause optic neuritis.
Polyarteritis NodosaVaccines have not been shown to cause polyarteritis nodosa.
Primary Ovarian Insufficiency (POI)Vaccines have not been shown to cause POI.
Transverse MyelitisVaccines have not been shown to cause transverse myelitis.
Serum SicknessVaccines have not been shown to cause serum sickness.
Small Fiber NeuropathyVaccines have not been shown to cause small fiber neuropathy.
Spontaneous AbortionMaternal vaccines have not been shown to cause spontaneous abortion.
StrokeVaccines have not been shown to cause stroke.
Sudden Infant Death Syndrome (SIDS)DTP and hepatitis B vaccines do not cause SIDS. Other vaccines have not been shown to cause SIDS.
Systemic Lupus Erythematosus (SLE)Vaccines have not been shown to cause SLE.
VasculitisVaccines have not been shown to cause vasculitis.
* These conclusions do not necessarily consider vaccines recommended only for special populations in the United States such as Yellow Fever vaccine (international travelers) or Smallpox vaccine (military personnel), or vaccines no longer recommended to the public such as the Janssen (J&J) COVID-19 vaccine.

References

1.         Institute of Medicine. In: Stratton K, Ford A, Rusch E, Clayton EW, eds. Adverse Effects of Vaccines: Evidence and Causality. Washington (DC): National Academies Press (US); 2012.

2.         Maglione MA GC, Das L, Raaen L, Smith A, Chari R, Newberry S, Hempel S, Shanman R, Perry T, Goetz MB. Safety of Vaccines Used for Routine Immunization in the United States. Evidence Report/Technology Assessment No. 215. Rockville, MD: Agency for Healthcare Research and Quality, July 2014. (www.effectivehealthcare.ahrq.gov/reports/final.cfm).

3.         Gidengil C, Goetz MB, Maglione M, et al. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Comparative Effectiveness Review No. 244. Rockville, MD: Agency for Healthcare Research and Quality, May 2021. (https://effectivehealthcare.ahrq.gov/products/safety-vaccines/research).

4.         Maglione MA, Das L, Raaen L, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics 2014;134(2):325-37. (In eng). DOI: 10.1542/peds.2014-1079.

5.         Gidengil C, Goetz MB, Newberry S, et al. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine 2021;39(28):3696-3716. (In eng). DOI: 10.1016/j.vaccine.2021.03.079.